▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4050 by analyst upside · 2026-11-13
LFCR
Lifecore Biomedical, Inc.
Healthcare · Market Cap $243M · P/E 0x
ANALYST PRICE TARGET
-1.9%
implied upside to consensus target
Current Price $6.4
Consensus Target $6.28
Bull Target $6.28
Bear Target $6.28
Analysts Covering 2
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
2
Sell
0
52-Week Low $3.63
52-Week High $8.98
YTD Return -17.3%
FUNDAMENTALS
Market Cap $243M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.27
PEG Ratio 2.66
Dividend Yield N/A
Revenue (TTM) $106M
Profit Margin -66.8%
52-WEEK RANGE
52-Week Low $3.63
52-Week High $8.98
Current Price $6.4
Bear Target $6.28
Bull Target $6.28
● Now $6.4 ● Target $6.28
TRADING DATA
Avg Volume 409K
YTD Return -17.3%
Analyst Count 2
Consensus Hold
Upside to Target -1.9%
Last Updated 2026-11-13

ANALYST SUMMARY

Lifecore Biomedical, Inc. (LFCR) is currently trading at $6.4 with a Wall Street consensus price target of $6.28, which is 1.9% below the current price over the next 12 months. 2 analysts currently cover LFCR, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $6.28, while the most cautious has a target of $6.28.

LFCR operates in the Healthcare sector with a market capitalisation of $243M. The stock is down 17.3% year-to-date and is currently trading near the upper end of its 52-week range of $3.63 – $8.98.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CYH +19.1%
Community Health Systems, Inc.
$312M · P/E 8.8x · Hold
VMD +31.7%
Viemed Healthcare, Inc.
$345M · P/E 24.0x · Buy
INFU +25.1%
InfuSystem Holdings, Inc.
$296M · P/E 32.9x · Buy
OPRX +38.7%
OptimizeRx Corporation
$167M · P/E 37.0x · Buy
CGEN +126.4%
Compugen Ltd.
$201M · P/E 5.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for LFCR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research ↓ Downgrade
Outperform → Market Perform 2026-09-29 Building track record
William Blair ↓ Downgrade
Outperform → Market Perform 2026-09-28 44% win rate (9 calls)
Barrington Research - Reiterated
Outperform → Outperform 2026-06-16 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-04-29 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-27 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-24 Building track record
Barrington Research ↑ Upgrade
Market Perform → Outperform 2026-03-17 Building track record
Keybanc ● Initiated
Sector Weight 2025-09-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
18
out of 100
Coverage depth
8/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →